Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity.

Human cell - 1 Jun 2011

Yasue Akira, Hasegawa Kiyoshi, Udagawa Yasuhiro

Abstract excerpt

This study was conducted to clarify the clinicopathological characteristics of tamoxifen-associated endometrial carcinomas and its mechanisms of carcinogenesis. Seven patients with tamoxifen-associated endometrial carcinomas (TAM group) and 28 with sporadic endometrioid adenocarcinomas (EMC group) were included in the study. The clinicopathological factors, such as FIGO stage, histological type, grade, lymph node...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial Neoplasms
Share to Genes, ras
Share to Microsatellite Instability

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MutL Protein Homolog 1

Share to MutS Homolog 2 Protein

Share to PTEN Phosphohydrolase

Share to Selective Estrogen Receptor Modulators

Share to Tamoxifen

Source

Identifiers

PMID: 21547354
DOI: 10.1007/s13577-010-0005-9

Genes

PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of tamoxifen on the endometrium and its mechanism of carcinogenicity.PMID 21547354Read ↗

Alterations of the K-ras and p53 genes in Tamoxifen-associated endometrial carcinoma.Semantic proximity Read ↗

Pathology of Endometrial Carcinoma.Semantic proximity Read ↗

MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases.Semantic proximity Read ↗

Molecular genetic characterization of tamoxifen-associated endometrial cancer.Semantic proximity Read ↗

Molecular pathology of endometrial hyperplasia and carcinoma.Semantic proximity Read ↗

Molecular basis of endometrial cancerSemantic proximity Read ↗

A case-case analysis of factors related to overexpression of p53 in endometrial cancer following breast cancer.Semantic proximity Read ↗

Endometrial carcinoma in tamoxifen-treated breast cancer patient: clinicopathological, immunohistochemical, and genetic analysis.Semantic proximity Read ↗

Review of the toxicology of tamoxifen.Semantic proximity Read ↗

Apoptosis as a possible candidate mechanism for removal of tamoxifen-related endometrial cells with KRAS mutations.Semantic proximity Read ↗

Bcl-2 and Ki67 expression in endometrial polyps in postmenopausal women and their association with obesitySemantic proximity Read ↗

Mutations and amplification of oncogenes in endometrial cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.